All News

Meet four patients with multiple myeloma who have found hope and improved quality of life by participating in endurance events.

Researchers developed SurVaxM to help stimulate an immune response in patients with glioblastoma.

“When learning about a second relapse, the only thing I could think was, ‘Oh no. Not again. This cannot be happening.”

Here is a list of the recent trial initiations that occurred within the myeloproliferative neoplasm cancer space.

A melanoma expert addresses the findings of two studies on the disease in children, adolescents and young adults, and shares ways in which they can protect themselves.

"I’m trying to turn my season of yes into a season of consideration. A season in which I weigh what I can do, with what I’d like to do, and with a radical honesty with my community around what that means and what a low-impact, beautiful, accepting, good life looks like. I hope that season lasts for a long time."

Here is a list of clinical trials that are currently happening within the mesothelioma space.

I have to admit I think about death a lot more since my two cancers, and I think that is OK.

When senior citizens gather to discuss our latest medical interventions, procedures and replacement parts - there's just one way to describe it.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

The V Foundation for Cancer Research, a top-rated cancer research charity, is excited to announce Olympic Gold Medalist Scott Hamilton will return to the ice on November 24 at Bridgestone Arena in Nashville, TN for the fourth annual ‘Scott Hamilton & Friends.'

Know your cancer before making a treatment decision.

In partnership with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the Food and Drug Administration (FDA) has granted supplemental approval to Calquence (acalabrutinib) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

The art of camouflage can be important for the breast cancer survivor choosing not to reconstruct.

While radiation therapy may be a common alternative for inoperable hepatocellular carcinoma, two new studies suggest that proton radiation therapy may offer the same benefits as the more traditionally used photon radiation therapy, with less toxicity.

Nearly one-quarter of inoperable intrahepatic cholangiocarcinomas shrank enough to make surgery possible after selective internal radiation was added to chemotherapy, a study shows.

The Food and Drug Administration approved Brukinsa to treat relapsed and refractory mantle cell lymphoma, but what does this mean for patients?

Having always thought of myself as someone who could handle anything, I learned that I didn’t have to do this on my own. Accepting help was okay

Both men and women have seen an increase in liver cancer diagnoses and death over the past nearly 20 years, according to new study findings.

Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.

“Live all you can, it’s a mistake not to. It doesn’t matter so much what you do in particular, so long as you have your life. If you haven’t had that, what have you had?”

Palliative care can make a huge difference for patients with cancer. Find out if it’s right for you.

After one woman’s father received a terminal stomach cancer diagnosis, she turned to Debbie’s Dream Foundation: Curing Stomach Cancer for information and guidance.

November is Stomach Cancer Awareness Month. Here's a round up of the latest news and updates in this disease space.

You never expect to get a diagnosis of cancer, but what about when it comes back?

While resistance can often make it a challenge to treat mantle cell lymphoma, therapies have come a long way in recent years thanks to the emergence of personalized treatment and the use of BTK inhibitors, according to one expert.

Pancreatic cancer doctors and researchers share what motivates them to do better for pancreatic cancer patients.

Researchers are expanding a clinical trial to include more patients with mantle cell lymphoma after some patients given the combination of medications under investigation showed no signs of cancer after treatment.